Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexapro for Major Depression in Epilepsy
NCT01244724Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Weill Cornell Medicine. Started Oct 2007; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01244724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244724.